Hepatoblastoma (HB) is the most common pediatric liver malignancy; however, hereditary
predisposition and acquired molecular aberrations related to HB clinicopathological …

Background & Aims Hepatoblastoma (HB) is the most common childhood liver cancer and
occasionally presents with histological and clinical features reminiscent of hepatocellular …

Background & Aims Hepatoblastoma (HB) is a rare disease. Nevertheless, it is the
predominant pediatric liver cancer, with limited therapeutic options for patients with …

Although hepatoblastoma is the most common pediatric liver cancer, its genetic
heterogeneity and therapeutic targets are not well elucidated. Therefore, we conducted a …

Despite being the most common liver cancer in children, hepatoblastoma (HB) is a rare
neoplasm. Consequently, few pretreatment tumors have been molecularly profiled, and …

Hepatoblastoma (HB) is the most common primary liver tumor in children. Mutations in the β‐
catenin gene that lead to constitutive activation of the Wnt pathway have been detected in a …

A number of unique genetic features are observed in hepatoblastoma that have provided
insights into the origins of hepatoblastoma. Hallmark cytogenetic changes in …

The identification of distinct types and subtypes of hepatoblastoma has led to a successful
classification of these lesions. In recent years, and particularly within large tumour trials, the …

Hepatoblastoma, the most common pediatric liver cancer, is tightly linked to excessive Wnt/β-
catenin signaling. Here, we used microarray analysis to identify two tumor subclasses …

Hepatoblastoma is the most common pediatric liver malignancy, typically striking children
within the first 3 years of their young lives. While advances in chemotherapy and newer …